These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 2875701)

  • 21. Neuroleptic malignant syndrome and malignant hyperthermia.
    Caroff S; Rosenberg H; Gerber JC
    J Clin Psychopharmacol; 1983 Apr; 3(2):120-1. PubMed ID: 6132930
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical picture and course of the neuroleptic malignant syndrome (acute febrile neuroleptic encephalopathy)].
    Avrutskiĭ GIa; Raĭskiĭ VA; Tsygankov BD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1391-6. PubMed ID: 3425085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Are catatonia and neuroleptic malignant syndrome related conditions?].
    Vesperini S; Papetti F; Pringuey D
    Encephale; 2010 Apr; 36(2):105-10. PubMed ID: 20434626
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis and treatment of neuroleptic malignant syndrome.
    Ebadi M; Pfeiffer RF; Murrin LC
    Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuroleptic malignant syndrome.
    Murray JB
    J Gen Psychol; 1987 Jan; 114(1):39-46. PubMed ID: 2881974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic-induced catatonia: neuroleptic malignant syndrome?
    de Leon J; Saiz-Ruiz J; Alonso-Abolafia A; Pico-Soler E; Munoz-Ruata J; de la Serna I
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):129-36. PubMed ID: 1967846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Detection and management of the neuroleptic malignant syndrome.
    Bond WS
    Clin Pharm; 1984; 3(3):302-7. PubMed ID: 6145537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychiatric Emergencies for Clinicians: Emergency Department Management of Neuroleptic Malignant Syndrome.
    Wilson MP; Vilke GM; Hayden SR; Nordstrom K
    J Emerg Med; 2016 Jul; 51(1):66-9. PubMed ID: 27247083
    [No Abstract]   [Full Text] [Related]  

  • 29. A protocol for the diagnosis and treatment of extrapyramidal symptoms of neuroleptic drugs.
    Bickal T
    Nurse Pract; 1987 Jan; 12(1):25, 29, 32 passim. PubMed ID: 2880325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Neuroleptic malignant syndrome and related conditions].
    Amore M; Montanari M
    Minerva Psichiatr; 1992; 33(4):259-83. PubMed ID: 1363674
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Report of a case involving haloperidol.
    Weinberger DR; Kelly MJ
    J Nerv Ment Dis; 1977 Oct; 165(4):263-8. PubMed ID: 908924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia.
    Komatsu T; Nomura T; Takami H; Sakamoto S; Mizuno K; Sekii H; Hatta K; Sugita M
    Intern Med; 2016; 55(19):2893-2897. PubMed ID: 27725556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Residual catatonic state following neuroleptic malignant syndrome.
    Caroff SN; Mann SC; Keck PE; Francis A
    J Clin Psychopharmacol; 2000 Apr; 20(2):257-9. PubMed ID: 10770467
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases.
    Harsch HH
    J Clin Psychiatry; 1987 Aug; 48(8):328-33. PubMed ID: 2886491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuroleptic malignant syndrome. Successful treatment with bromocriptine.
    Mueller PS; Vester JW; Fermaglich J
    JAMA; 1983 Jan; 249(3):386-8. PubMed ID: 6129331
    [No Abstract]   [Full Text] [Related]  

  • 36. Functional hyperthermia due to central dopaminergic impairment.
    Di Rosa AE; Morgante L; Coraci MA; Crisafulli A; Cacciola G; Di Stefano G; Meduri M; Di Perri R
    Funct Neurol; 1988; 3(2):211-5. PubMed ID: 2900182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differential diagnosis of acute life threatening catatonia and malignant neuroleptic syndrome--a case report].
    Hermle L; Oepen G
    Fortschr Neurol Psychiatr; 1986 Jun; 54(6):189-95. PubMed ID: 2873091
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Neuroleptic malignant syndrome in users of risperidone].
    Gerritsen AA; de Jonghe-Rouleau AP; Stienstra-Liem LH
    Ned Tijdschr Geneeskd; 2004 Sep; 148(37):1801-4. PubMed ID: 15495506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Neuroleptic malignant syndrome : Rare cause of fever of unknown origin].
    Chackupurakal R; Wild U; Kamm M; Wappler F; Reske D; Sakka SG
    Anaesthesist; 2015 Jul; 64(7):527-31. PubMed ID: 26122200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome?
    Daras M; Kakkouras L; Tuchman AJ; Koppel BS
    Acta Neurol Scand; 1995 Aug; 92(2):161-5. PubMed ID: 7484066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.